ENDOTHELIAL SPECIFIC TARGETING

Patent №

US 6,974,791

Granted

2005-12-13

Filed 2001

Owner

PITTSBURGH, UNIVERSITY OF

Lab

AI components

1

vision

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09810700

Peptide motifs which define specificity of tumor-derived endothelial cells. These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium. The specific molecular peptide motifs will facilitate diverse therapeutic and diagnostic applications including: anti-angiogenic therapies to be used in alone or in conjunction with standard therapies; imaging tools for both detection of very small metastasis that are undetectable by current techniques; for monitoring tumor response; for targeting and directing chemotherapy drugs to the tumor; for treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis, for treating some forms of blindness; as well as other diagnostic and therapeutic applications.

VisionC07K 7/06A61K 47/64A61P 29/00A61P 35/00A61K 38/00

AI classification

Vision0.80
Natural language0.00
AI hardware0.00
Evolutionary computation0.00
Machine learning0.00
Speech0.00
Planning0.00
Knowledge representation0.00

Ownership

PITTSBURGH, UNIVERSITY OF

assignment · 122810987

Assignors

WONG, MICHAEL K., MODZELEWSKI, RUTH A., BROWN, CHARLES KOMEN, JOHNSON, CANDACE S., TRUMP, DONALD J.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC